Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 5/20 | 0.47 |
| ▸ | MRGPRX1 | Q96LB2 | 5/20 | 0.33 |
| ▸ | TSPO | P30536 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1862039 | 1.00 | TLR4 (0.47) | TLR4MRGPRX1TSPOKMT2ALMNA | |
| SCHEMBL4151044 | 0.92 | TLR4 (0.48) | TLR4MRGPRX1KMT2AHTR7POLB | |
| SCHEMBL4153914 | 0.92 | TLR4 (0.48) | TLR4MRGPRX1KMT2AHTR7POLB | |
| SCHEMBL17727732 | 0.92 | TLR4 (0.48) | TLR4MRGPRX1KMT2AHTR7POLB | |
| SCHEMBL1862038 | 0.87 | TLR4 (0.57) | TLR4MRGPRX1TSPOLMNATP53 | |
| SCHEMBL1863367 | 0.87 | TLR4 (0.57) | TLR4MRGPRX1TSPOLMNATP53 | |
| SCHEMBL4150878 | 0.84 | TLR4 (0.47) | TLR4MRGPRX1KMT2ALMNATP53 | |
| SCHEMBL4146695 | 0.84 | TLR4 (0.47) | TLR4MRGPRX1KMT2ALMNATP53 | |
| SCHEMBL4140826 | 0.83 | TLR4 (0.47) | TLR4MRGPRX1TSPOKMT2ALMNA | |
| SCHEMBL4157181 | 0.82 | TLR4 (0.50) | TLR4MRGPRX1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7935835-B2 | Substituted cycloalkene derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-05-03 | — | — | US | disclosed |